GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Up 934.4% in March

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 33,100 shares, an increase of 934.4% from the February 28th total of 3,200 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 1,865,900 shares, the days-to-cover ratio is presently 0.0 days.

GlobeStar Therapeutics Stock Performance

OTCMKTS GSTC traded down $0.00 during trading on Thursday, hitting $0.00. 2,615,000 shares of the company’s stock traded hands, compared to its average volume of 3,260,735. GlobeStar Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.00.

GlobeStar Therapeutics Company Profile

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.